Business OpportunityUpdated on 14 November 2025
mHealthysleep – Improving patients sleeping quality at home – Early detection, assessment, and personalised management of sleep disorders at home.
IBEC - Technology Transfer and Business Development manager at Institute for Bioengineering of Catalonia (IBEC)
Spain
About
Obstructive sleep apnea (OSA) is a common sleep disorder, especially in older people, affecting 9-38% of the population. It causes intermittent oxygen deprivation and sleep disruptions, leading to fatigue and daytime sleepiness. Without treatment, OSA significantly increases the risk of cardiovascular and cerebrovascular diseases.
MHealth is a mobile based system for home diagnosis, sleep monitoring and treatment of OSA and sleep disorders. With MHealth, we enable early detection of sleep disorders through multi-night, at home monitoring. It supports diagnosis, personalized positional therapy, and sleep quality measurements offering an unseen combination in smartphone-based medical devices for sleep disorders.
The key strengths of our technology are:
- A diagnostic algorithm that integrates audio and accelerometer signals coming from a mobile phone device using simple wearables (optional use of an oximeter).
- A personalised and high-resolution sleep position monitoring, by calculating the sleep angle, and its correlation with apnea events (current methods consider just four classical positions).
- Positional therapy based on the programmable vibration of the mobile phone. It can be delivered from the app to avoid sleeping in apnea-inducing angles, thus reducing obstructive events.
The implementation of mHealthSleep seeks after a reduction in the health and economic costs of sleep disorders, offering a technology that can easily reach more patients (even in mild stages of the disease) and facilitate primary care access to sleep disorder screening, unobtrusive remote monitoring, positional therapy delivery, and personalized follow-up at home.
Stage
- TRL 6
Topic
- Bioinformatics
- Diseases of the nervous system / neurology
- Respiratory
Sector
- Health data
- Diagnostics
Type
- Clinical validation
Organisation
Similar opportunities
Business Opportunity
- AI
- Other
- Other
- Health data
- Consortium partners
- Endocrine/nutritional/metabolic diseases
Violeta Moize
Nutritionist, Ph.D - Obesity specialist at Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (DIBAPS)
Barcelona, Spain
Business Opportunity
AI-powered Healthcare with therapeutic red blood cells
- AI
- TRL 6
- ATMPs
- Health data
- Diagnostics
- Rare diseases
- Rare diseases
- Co-development
- Clinical validation
- Regenerative medicine
- Endocrine/nutritional/metabolic diseases
- Diseases of the nervous system / neurology
- Mental and behavioural disorders / psychiatry /psychology
Denis Demarais
Founder and CEO at Rius Medical
Waldachtal, Germany
Business Opportunity
vitalera: Making Hospital-at-Home a Reality with AI
- AI
- TRL 8
- Oncology
- Physiology
- Pediatrics
- Licensing
- Respiratory
- Health data
- Rare diseases
- Rare diseases
- Bioinformatics
- Cardiovascular
- Co-development
- Digestive system
- Consortium partners
- Regenerative medicine
- Research collaboration
- External causes of morbidity, mortality
- Injury, poisoning, other external causes
- Pregnancy, childbirth and the puerperium
- Musculoskeletal system, connective tissue
- Other symptoms, deviant clinical findings
- Diseases of the blood and immune disorders
- Diseases of the nervous system / neurology
- Mental and behavioural disorders / psychiatry /psychology
Nuria Pastor
General Manager at vitalera
Barcelona, Spain